-
Hegseth blasts NATO allies, says US will review forces in Europe
-
Cuban economy needs 'urgent changes' to overcome crisis: president
-
Greenland sees wildfires earlier in the year
-
US Open resumes after two-hour fog delay
-
The vaccines and treatments being developed for Ebola outbreak
-
Spanish king to visit Mexican president on June 25 as ties improve
-
Ton-up Phillips stars for New Zealand against England
-
Wahi denied Canadian visa for Ivory Coast World Cup clash with Germany
-
Swiss central bank holds interest rates, with eye on currency risks
-
S.African sentenced in 'world's largest' rhino trafficking case
-
Bank of England follows Fed in holding interest rate
-
Bittersweet World Cup for Gaza's football fans
-
Trump defends Iran deal from critics he calls 'fools'
-
New heatwave disrupts trains, schools in France
-
German chemical company to cut 3,200 jobs as crisis worsens
-
Starmer's Labour rival eyes win in UK poll key to PM's fate
-
Oil falls further on Mideast deal, but Fed outlook knocks equities
-
Mexico, Korea eye World Cup knockout berths
-
Range raises $8.3M Series A to unify treasury, risk and compliance across stablecoins and fiat
-
IAEA ready to help define 'concrete steps' to implement US-Iran deal
-
Ibrahima Konate signs four-year deal with Real Madrid
-
Hegseth tells NATO US will review force presence in Europe
-
Innovations on show at Paris Vivatech fest
-
Ukraine sets Moscow refinery ablaze in biggest attack in years
-
Bird flu kills 13,000 seal pups on remote Australian island
-
Oil prices sink further as Trump signs deal to reopen Hormuz
-
South Korean lawmakers launch probe into ballot paper shortages
-
Starmer rival seeks win in UK poll pivotal to PM's fate
-
Taiwan president says hopes for $14 bn US arms sale 'as soon as possible'
-
Why are Kenyan kids burning schools and killing their classmates?
-
New wave of anti-LGBTQ laws sweeps Africa
-
Ukraine hopes renewables can Russia-proof power grid
-
Jubilant New York on guard for Knicks parade
-
What we learned after the first round of World Cup games
-
New Zealander Manu has 'no fear' of Toulouse before Top 14 semi
-
Drastic restrictions on public transport take effect in Cuba
-
Pain-riddled South Korean man fights for right to die
-
Cuba approves economic reforms to boost private sector, investment: state TV
-
India learns to live with hotter summers
-
'Retired' Wallaby Slipper, 37, set for shock international comeback
-
EU wrestles over how to tackle China export flood
-
Tartan Army takes over Boston as Scotland fans relish World Cup return
-
Comedian Jordan Klepper wishes satire was harder in age of Trump
-
Robots pour cocktails and run marathons, but still can't multitask
-
Birthright citizenship helps spark US World Cup run
-
Ghana beat Panama 1-0 in World Cup opener after injury-time winner
-
Castro gives crucial backing to Cuba reforms
-
Jericho Energy Ventures Grants Incentive Stock Options
-
Spirit Blockchain Capital Announces Shares For Services Issuance
-
AI Financial Corporation Integrates USDU Stablecoin to Expand Regulated Digital Asset Settlement Capabilities in the UAE
Jared Leto on joining Marvel and turning into a vampire
Jared Leto has been a star for decades, but it's only now at 50 that he is fronting his first major blockbuster -- transforming into a vampire for new Marvel flick "Morbius".
Leto made his name in more independent and cult projects, such as his Oscar-winning turn in AIDS drama "Dallas Buyer's Club" or as a junkie in "Requiem for a Dream".
But he has no qualms about joining the superhero juggernaut with "Morbius", that is hitting cinemas around the world next week.
"You want Marvel to help pay the bills, then you can sneak in some other movies here and there," he told AFP during a visit to Paris.
"I'm excited. I've done a lot of smaller roles in bigger movies and made a career out of that, so it's interesting to star in a movie thats something new and different -- I like a big, fun popcorn movie."
Leto is not a total stranger to superhero flicks, of course, having taken a turn as the Joker in "Suicide Squad".
But now he is creating a character not yet seen in the Marvel Cinematic Universe: Dr Michael Morbius is a scientist suffering from an incurable disease who accidentally turns himself into a vampire while trying to find a cure, and then can't stop killing people for their blood.
"He's not exactly a hero, not a villain. He's somewhere in between -- there's a classic Jekyll and Hyde thing happening here," said Leto.
"I liked that there were three characters built into one. There was a significant transformation between them."
- 'I never watch them' -
For once, Leto was spared the extensive make-up, unlike his almost unrecognisable turn in last year's "The House of Gucci", or the fake nose and teeth he used for his creepy serial killer in "The Little Things".
"Originally they wanted to use prosthetics with the monster and I pushed them to embrace technology and CGI. I'm glad we did because it gave us a lot more freedom," he said, referring to computer generated imagery.
"I worked with people that have rare diseases. There was a certain way of walking that's actually common with stroke survivors. I didn't want to just get a cane and have a little limp or something -- I wanted to make it specific."
Leto first became a star in the 1990s as the heart-throb in teen drama "My So-Called Life" and has popped up in lots of cult favourites, including "Fight Club", "American Psycho" and "Blade Runner 2049".
Not that he has seen any of these -- Leto hasn't watched himself on screen since the premiere of "Requiem for a Dream" at Cannes in 2000.
"I never watch them. The whole goal as an actor is to be unselfconscious. So I do everything I can not to be thinking about myself from the outside," he said.
"That way, I never repeat myself. Maybe that's why my characters are so different."
E.Rodriguez--AT